Metagenomi IPO Triumph: $93.75M Secured for Healthcare Innovations
Metagenomi, a biotech pioneer, achieves remarkable success with a $93.75M IPO on Nasdaq. The capital boost positions them to lead ...
- Latest
- Trending
Metagenomi, a biotech pioneer, achieves remarkable success with a $93.75M IPO on Nasdaq. The capital boost positions them to lead ...
Akamai Technologies reported strong EPS but fell short on revenue for Q4 2023. Despite this, compute services revenue showed growth ...
Esports Entertainment Group will delist from Nasdaq to cut costs and focus on growth, transitioning to the OTCQB Venture Market ...
E-commerce startup Bolt offers a buyback program for investors and employees, highlighting its struggling financial situation. Tribe Capital is selling ...
Xponential Fitness is facing a class action lawsuit over securities fraud allegations for not disclosing franchisee financial struggles and misleading ...
Hudson Pacific Properties, Inc. reports decline in net income for Q4 2023 due to asset sales and decrease in total ...
Flame Acquisition Corp's stockholders have approved the merger with Sable Offshore, paving the way for expansion in North America. The ...
BioVaxys Technology Corp. finalizes agreement to acquire IMV Inc.'s immunotherapy technology portfolio, expanding its cancer vaccine portfolio and positioning itself ...
Presto Automation secures $6 million in financing, led by current investors. Company's AI Voice product shows significant growth. Court upholds ...
Gilead Sciences plans to acquire CymaBay Therapeutics for $4.3 billion, expanding their liver disease portfolio. The deal is expected to ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.